CHTR vs REGN · P/E 11, rev $55.09B vs P/E 14, rev $14.34B
Charter Communications Inc (CHTR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CHTR and REGN stock pages for the full models.
Not investment advice.